Showing results (561-570 of 586) with videos related to

Sort By:
Pageof 59
Infectious Diseases and Therapy|February 20, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial DecisionsStephen J Balevic, Shruti M Raja, Rachel Randell, et al.
The Journal of Biological Chemistry|September 17, 2014
A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cellsTameka A Bailey, Haitao Luan, Eric Tom, et al.
Frontiers in Neurology|February 28, 2017
B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease SeverityJohn S Yi, Melissa A Russo, Janice M Massey, et al.
Biotechnology Reports (Amsterdam, Netherlands)|April 24, 2026
From screening to sequencing: Investigating the monoethylene glycol (MEG) biodegradation by Stutzerimonas stutzeri EX72 strain to optimize Oil and Gas industrial produced water treatmentMohammad Yousaf Ashfaq, Gaurav Thareja, Farhan A Khan, et al.
Annals of Hematology|June 2, 2000
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemiaH T Greinix, H Loidolt, W Rabitsch, et al.
Developmental Neuroscience|June 10, 2025
Developmental Progression of Inhibitory Control and Flexible Problem-solving Among Infants with Histories of Preterm BirthSrishti Jayakumar, Ezequiel Ramos, Kathryn A Carson, et al.
The Journal of Biological Chemistry|March 21, 1997
Molecular and functional characterization of the urokinase receptor on human mast cellsC Sillaber, M Baghestanian, R Hofbauer, et al.
Cancers|August 27, 2021
CHIP/STUB1 Ubiquitin Ligase Functions as a Negative Regulator of ErbB2 by Promoting Its Early Post-Biosynthesis DegradationHaitao Luan, Tameka A Bailey, Robert J Clubb, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2022
First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin ES M Raja, J T Guptill, V C Juel, et al.
Cancer Biology & Therapy|November 20, 2010
Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancersSrikumar M Raja, Robert J Clubb, Cesar Ortega-Cava, et al.
Pageof 59